Zacks Research Analysts Increase Earnings Estimates for TEVA
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Research analysts at Zacks Research increased their Q1 2025 earnings per share estimates for Teva Pharmaceutical Industries in a research report issued on Wednesday, November 27th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.48 per share for the quarter, […]
More Stories
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Short Interest Down 8.5% in November
Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) saw a significant decline in short interest in November. As of November...
Okta (NASDAQ:OKTA) Shares Gap Up on Analyst Upgrade
Okta, Inc. (NASDAQ:OKTA – Get Free Report) gapped up prior to trading on Wednesday after Scotiabank raised their price target...
Danaos Co. (NYSE:DAC) Short Interest Up 8.1% in November
Danaos Co. (NYSE:DAC – Get Free Report) saw a large increase in short interest during the month of November. As...
Bowhead Specialty (NYSE:BOW) Hits New 52-Week High on Analyst Upgrade
Bowhead Specialty Holdings Inc. (NYSE:BOW – Get Free Report) shares reached a new 52-week high on Wednesday after Keefe, Bruyette...
inSure DeFi Price Up 27.5% Over Last 7 Days (SURE)
inSure DeFi (SURE) traded up 12.4% against the US dollar during the twenty-four hour period ending at 12:00 PM E.T....
CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Significant Increase in Short Interest
CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW – Get Free Report) saw a significant increase in short interest in the month of...